SHL Telemedicine Calls Special General Meeting
Ticker: SHMLF · Form: 6-K · Filed: Aug 12, 2025 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
SHL Telemedicine is holding a special meeting for shareholders on Aug 12, 2025 - vote on company matters.
AI Summary
On August 12, 2025, SHL Telemedicine Ltd. announced an invitation to a Special General Meeting. The purpose of this meeting is to discuss and vote on important company matters. The announcement was made via a press release furnished as Exhibit 99.1 to this 6-K filing.
Why It Matters
Shareholders will have the opportunity to vote on key company decisions, potentially impacting the future direction and governance of SHL Telemedicine Ltd.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting and does not contain significant financial or operational news.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- August 12, 2025 (date) — Date of press release and meeting invitation
FAQ
What is the purpose of the Special General Meeting announced by SHL Telemedicine Ltd.?
The purpose is to invite shareholders to a Special General Meeting to discuss and vote on company matters, as detailed in the press release.
When was the press release announcing the Special General Meeting issued?
The press release was issued on August 12, 2025.
What exhibit number is the press release furnished under in this 6-K filing?
The press release is furnished as Exhibit 99.1.
What is the principal executive office address of SHL Telemedicine Ltd.?
The principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Does SHL Telemedicine Ltd. file annual reports under Form 20-F?
Yes, the company indicates it files annual reports under cover of Form 20-F.
Filing Stats: 184 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-08-12 12:21:00
Filing Documents
- zk2533625.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 6KB
- image0.jpg (GRAPHIC) — 266KB
- 0001178913-25-002801.txt ( ) — 383KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL TELEMEDICINE LTD. By: /s/ Lior Haalman Lior Haalman Chief Financial Officer August 12, 2025